Neurobiology of Stress, Volume 29, March 2024
This article discusses the association between stress exposure, alcohol consumption, and Alzheimer's Disease and related dementias (ADRD), emphasizing the importance of understanding behaviors that impact neurodegeneration and cognitive decline, and the need for preclinical research to uncover the underlying biological mechanisms.
Elsevier,
Advances in Nutrition, Volume 15, March 2024
In the field of nutrition and brain aging research, dietary patterns, particularly the MIND diet, are a prominent area of interest. This systematic review provides an overview of studies examining the MIND diet in relation to brain aging. It updates previous systematic reviews with respect to cognition, cognitive decline, and dementia and extends to other brain aging outcomes including Parkinson’s disease, brain volume, and pathology.
Elsevier,
Water Research, Volume 252, 15 March 2024
In this study, we introduced an integrated assessment framework, and estimated both quality and quantity-related Water Scarcity Index (WSI), local economic water scarcity risk (WSR), and the cascading virtual WSR observed in global trade markets across 40 major economies spanning from 1995 to 2010. Results show that developing countries had rapid growth in both quantity and quality-related WSI, while major developed economies experienced a modest increase in water stress but mitigated quality-related risks, suggesting imbalanced progress towards SDG 6 across countries.
Elsevier,
The Lancet Regional Health - Western Pacific, Volume 44, March 2024
This Review supports SDG 3 by describing the national response to hepatitis B and C virus in Viet Nam and the Philippines, finding that although both countries have robust policies, there are differences between them in political commitment, funding, and engagement
Elsevier,
eClinicalMedicine, Volume 69, March 2024
This Article supports SDG 3 by showing that providing hepatitis C testing services in pharmacies would be beneficial in increasing case detection, in keeping with growing evidence showing the benefits of providing hepatitis services in community settings. Further research is needed to evaluate the provision of hepatitis C treatment, and hepatitis B testing and treatment, in pharmacies
